|
Volume 272, Number 50, Issue of December 12, 1997
pp. 31308-31314
Effects of Intravesicular H+ and Extracellular
H+ and Zn2+ on Insulin Secretion in Pancreatic
Beta Cells*
(Received for publication, August 6, 1997, and in revised form, October 3, 1997)
Craig A.
Aspinwall
,
Sunday A.
Brooks
,
Robert T.
Kennedy
§ and
Jonathan R. T.
Lakey
¶
From the Department of Chemistry, University of
Florida, Gainesville, Florida 32611-7200 and the ¶ Comprehensive
Tissue Center, Department of Surgery, University of Alberta, Edmonton,
Alberta T6H 2R8, Canada
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The effects of extracellular
Zn2+ and pH and intravesicular pH on insulin and
5-hydroxytryptamine (5-HT) secretion from pancreatic beta cells were
investigated. Insulin and 5-HT secretion from single cells was detected
by amperometry as a series of current spikes corresponding to detection
of multimolecular packets secreted by exocytosis. Spike width was used
as a measure of the kinetics of clearance from the cell and the area of
spikes as a measure of amount released. Changes in extracellular pH
from 6.9 to 7.9 caused insulin spikes to become narrower with no change
in area, whereas the same treatments had no effect on 5-HT secretion.
Treatment of cells with Bafilomycin A1 or
N-ethylmaleimide, both of which are expected to increase
intravesicular pH by inhibiting V-type H+-ATPase, had no
effect on 5-HT secretion but caused insulin spikes to become more
narrow. These results indicate that exposure to high pH, whether
intravesicular or extracellular, accelerates release of insulin during
exocytosis without affecting the amount of insulin released. Increasing
extracellular Zn2+ concentration from 0 to 25 µM increased the width and decreased the area of insulin
spikes without affecting 5-HT secretion. Zn2+ effects were
likely exerted through a common-ion effect on Zn2+-insulin
dissociation. It was concluded that intravesicular storage conditions
and extracellular ions can affect free insulin concentration in the
vicinity of beta cells during secretion.
INTRODUCTION
Insulin, produced and stored in pancreatic beta cells, is released
by exocytosis in response to external stimuli, such as elevated glucose
concentration. A greater understanding of exocytosis in beta cells is
of intense interest because of the possible role of defective insulin
secretion in type II diabetes (1, 2). Secretion by exocytosis can be
considered to occur in several steps including vesicle docking, vesicle
priming, vesicle fusion, and finally extrusion or clearance of
vesicular contents into the extracellular medium (3). In this study, we
examined the postfusion clearance of insulin from beta cell secretory
vesicles during exocytosis.
Clearance of insulin from secretory vesicles is intimately related to
the storage of insulin within a vesicle. Insulin is generally believed
to be stored inside secretory vesicles as a solid hexamer bound with
two Zn2+ ions per hexamer (4-6). This understanding is
supported by a broad spectrum of evidence. It is known that in the
presence of Zn2+, insulin will form tetramers and hexamers
that bind Zn2+ in an insulin:Zn2+ ratio of 4:1
and 6:2, respectively (5), and that vesicles contain Zn2+
in 1-1.5-fold excess of that necessary to form
Zn2+-insulin hexamers (7). Zn2+-insulin
hexamers are insoluble below pH 7 (5, 6, 8, 9), and beta cell secretory
vesicles possess a V-type H+-ATPase that maintains the
vesicle interior at or below pH 6 (10, 11). Electron micrographs and
immunohistology also suggest the presence of solid insulin inside
vesicles (12, 13). During exocytosis, secretory vesicles fuse with the
plasma membrane, exposing the vesicular interior to the extracellular
milieu, allowing release of stored insulin granules. It is apparent
that insulin must dissolve to escape the vesicle. In addition, insulin
must dissociate from Zn2+ because insulin monomer is the
biologically active form (14, 15). Little is known about the mechanism
or time scale of dissolution and dissociation, although one study has
demonstrated that insulin is free from Zn2+ within 60 s of release (4). Additional investigation of this phenomenon has been
hindered by the lack of methods for monitoring insulin secretion with
sufficient temporal resolution to observe such effects.
Recently, amperometry with microelectrodes has been applied to the
study of exocytosis at a variety of cell types, including adrenal
chromaffin cells (16-19), PC12 cells (20), mast cells (21), neurons
(22), and melanotrophs (23, 24). Secretion is detected as a series of
current spikes that correspond to detection of concentration pulses
generated by exocytosis. Analysis of current spikes can reveal subtle
details about secretion. The area of current spikes (measured in
coulombs) can be used to quantitate the moles of detected hormone (or
transmitter) released per vesicle using Faraday's Law (19). The
dynamics of vesicular release are reflected in the shape of the current
spikes. Specifically, the width of spikes can be used as a measure of
the rate of clearance from the vesicle because the width is determined
by any slow kinetic step involved in clearing hormone from the vesicle
and diffusional broadening of the secreted packet of molecules
(25-28). Thus, the exquisite temporal resolution and sensitivity of
amperometry for measuring actual secretory products has made it well
suited for probing postfusion events in exocytosis (25-27, 29,
30).
We have extended amperometry to detection of insulin exocytosed from
pancreatic beta cells (31, 32). For this application, a carbon-fiber
electrode modified with ruthenium oxide/cyanoruthenate (Ru-O/CN-Ru), a
catalyst that promotes oxidation of insulin, is used for detection.
This method has allowed the first direct measurement of exocytosis of
insulin from single beta cells with high temporal resolution (32). In
using amperometry to study postfusion events in insulin release, we
have found it useful to measure
5-HT1 release as a control.
5-HT can be "loaded" into beta cells by incubating the cells in
medium containing both 5-HT and 5-hydroxytryptaphan. Substantial
evidence now exists that demonstrates that 5-HT is loaded primarily
into beta cell secretory vesicles and that 5-HT is co-secreted with
insulin by exocytosis
(34-36).2 5-HT can be
detected at bare carbon electrodes and insulin can be detected only at
Ru-O/CN-Ru-modified electrodes. Thus, it is possible to measure, in
separate experiments, secretion of 5-HT from loaded cells and secretion
of insulin from cells that have not been allowed to accumulate
5-HT.
In an initial study on postfusion clearance of insulin, we found that
exposure to a pH gradient between the vesicle and the extracellular
environment is required to achieve rapid release of free insulin from
solid Zn2+-insulin granules (37). In the present study, we
extended this investigation to a variety of extracellular pH values. In
addition, we examined the effect of intravesicular pH and extracellular Zn2+ on insulin secretion. The study reveals strong effects
of the extracellular and intravesicular environments on the rate and amount of free insulin released during exocytosis.
MATERIALS AND METHODS
Electrode Preparation and Testing
Carbon fiber
microelectrodes were constructed as described previously (38, 39).
Finished electrodes consisted of a 9 µm carbon fiber (P-55S, Amoco
Performance Products) sealed with epoxy (Miller Stephenson, Danbury,
CT) in the tip of a glass pipette. The total electrode diameter at the
tip was ~30 µm, and the electrode was polished at a 30-45° angle
using a pipette beveler (BV-10, Sutter Instruments). For detection of
insulin, electrodes were chemically modified as described previously to
produce a mixed valent Ru-O/CN-Ru film (32), whereas 5-HT detection was
performed with bare carbon fiber microelectrodes (34).2
Tests of the electrode response to insulin and 5-HT were performed by
positioning the tips of electrodes approximately 10 µm from micropipette tips (outer diameter, 30 µm) under a Krebs-Ringer buffer
solution on the stage of a microscope. Solutions were pressure-ejected from the tips of the pipettes at 9 p.s.i. for 5 s while the
amperometric current was recorded.
Data Collection and Analysis
Amperometry was performed
using a battery to apply potential to a sodium-saturated calomel
electrode. Currents were monitored at the working electrode using an
AI-403 current amplifier and Cyberamp 320 signal conditioner (Axon
Instruments, Foster City, CA). For detection of 5-HT, the potential at
the working electrode was 0.65 V, whereas for detection of insulin, the
potential was 0.85 V. All voltages are versus a sodium-saturated
calomel electrode. When using the modified electrode, the potential was
held at 0.40 V between recordings to improve electrode stability as
described elsewhere (32). Data were low pass filtered at 300 Hz for
insulin measurements and at 1000 Hz for 5-HT. These filter settings
were found to not affect the peak widths relative to higher settings. Data were collected at a rate that was three to five times the filter
frequency using a personal computer (Gateway 2000 P5-166) via a data
acquisition board (DigiData 1200B, Axon Instruments). The area and
half-width of current spikes were calculated using software provided by
Prof. R. Mark Wightman (University of North Carolina). For data
analysis, spikes were used only if the signal:noise ratio was greater
than 10. All means are reported ± 1 S.E. Statistical differences
between means were evaluated using a two-tailed Student's t
test.
Isolation of Canine Islets and in Vitro Culture
Unless
otherwise stated, all chemicals for islet and cell culture were
obtained from Life Technologies. Pancreatic islets were isolated from
mongrel dogs using controlled collagenase (Boehringer Mannheim)
perfusion via the duct, automated dissociation, and discontinuous
Euro-Ficoll purification using the COBE 2991 blood cell processor as
described previously (40, 41). Following isolation, groups of islets
were placed in modified CMRL 1066 tissue culture solution (G-100)
containing 10% fetal calf serum, 25 mM HEPES, 100 units/ml
penicillin, and 100 µg/ml streptomycin and shipped overnight. Upon
arrival, islets were immediately dispersed into single cells using a
previously described procedure (32). Cells were plated onto tissue
culture dishes (Corning) and incubated at 37 °C in 5%
CO2 in G-100, pH 7.4.
Accumulation of 5-Hydroxytryptamine into Beta Cells
For
experiments requiring measurement of 5-HT secretion, dispersed beta
cells were allowed to incubate in G-100 containing 0.5 mM
5-HT and 1 mM 5-hydroxytryptophan for 16 h at 37 °C
in 5% CO2, pH 7.40 (37).2 Cells were used for
secretion experiments immediately after loading.
Single Cell Experiments
Single cell measurements were
performed similar to those described elsewhere (19, 23, 31). All
amperometric experiments were performed on a Zeiss Axiovert 100 inverted microscope. Cells were bathed in Krebs-Ringer buffer, pH 7.4 containing 118 mM NaCl, 5.4 mM KCl, 2.4 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, 25 mM
NaHCO3, 0.010 mM forskolin (42), and 3.0 mM D-glucose and maintained at 37 °C and 5%
CO2 on the stage of the microscope by a microincubator (Medical Systems, Inc.). Buffer pH was adjusted by varying the bicarbonate concentration to achieve the desired pH after bubbling with
5% CO2. Extracellular Zn2+ concentration was
adjusted by adding ZnCl2 to the desired concentration. Ionic strength was held constant for all solutions. When appropriate, cells were incubated in G-100 containing either 50 µM
N-ethylmaleimide or 1 µM Bafilomycin
A1 for 30 min. Amperometry was performed at isolated single
cells by positioning the sensing tip of the microelectrode 1 µm from
the cell using a micromanipulator (PCS-250, Burleigh Instruments).
Stimulant solution (200 µM tolbutamide in bicarbonate buffer) was applied to individual cells by pressure ejection for 10 s from a micropipette positioned ~30 µm from the cell.
Simulation of Spike Shape
A random-walk model was used to
simulate diffusion-limited current spikes obtained from exocytosis
(43). In the model, the cell was considered a hemisphere with a radius
of 5 µm, and the electrode was centered directly over the apex of the
cell, with a 1.0-µm gap between the cell and the electrode. An
exocytosis event was modeled as a point source of 50,000 molecules
diffusing from a location on the cell surface to the electrode. Thus,
exocytosis events originating at the base of the cell travel farther to
the electrode than exocytosis events originating at the apex of the cell, where the distance to the electrode was minimized. Molecules encountering the electrode were counted as detected and were removed from the system. Molecules encountering the cell membrane or the insulating portions of the electrode were reflected back to their previous position. The simulation was ended when all molecules were
detected or after 3000 steps had been made in the walk. Longer random
walks did not affect the results. For the model, 5-HT and insulin were
considered to have diffusion coefficients of 6.0 × 10 6 and 2.0 × 10 6 cm2/s,
respectively (31).
RESULTS
Effect of Zn2+ on Insulin Detection
We have
previously used the Ru-O/CN-Ru electrode to detect insulin and insulin
secretion (31, 32). An issue that has not been addressed but that is
important in the interpretation of these data is the effect of
Zn2+ complex formation on insulin detection. Fig.
1 illustrates current recorded during
injection of Krebs-Ringer buffer solutions that contained 30 µM insulin (A) or 30 µM insulin
along with 15 µM Zn2+, which promotes the
formation of Zn2+-insulin complexes (B). As the
data show, addition of Zn2+ abolished the signal obtained
from detection of insulin. The presence of Zn2+ did not
affect the detection of other, non-Zn2+ binding compounds,
such as 5-HT (Fig. 1, C and D). These results strongly suggest that the electrode detects free insulin and not insulin complexed with Zn2+.
Fig. 1.
Amperometric detection of free and
Zn2+-complexed insulin. Current traces are recordings
of 30 µM insulin (A), 30 µM insulin with 15 µM zinc (B), 5 µM 5-hydroxytryptamine (C), and 5 µM 5-hydroxytryptamine with 15 µM zinc
(D), all dissolved in Krebs-Ringer buffer, applied to a
Ru-CN/Ru-O-modified microelectrode by pressure ejection as described
under "Materials and Methods." Current scale shown in A
also applies in B, and that shown in C also
applies in D.
[View Larger Version of this Image (8K GIF file)]
Spike Width Analysis
Fig. 2
compares high resolution recordings of spikes resulting from detection
of insulin and 5-HT. Several differences in spike shape were observed
for detection of 5-HT and insulin. The most marked difference in shape
of the spikes was that the average width at half-height of 5-HT spikes
was 5.3 ± 0.4 ms, which is significantly lower (p < 0.0005) than the 30 ± 2.1 ms obtained for insulin spikes. As
mentioned under "Introduction," the width at half-height of a
current spike is a measure of the time required for detected material
to extrude from a vesicle, diffuse to the electrode, and be detected.
Thus, some of the difference in width could be attributed to the
difference in diffusion coefficient for 5-HT and insulin. The random
walk model, which predicts widths based solely on diffusion, indicates
that the insulin spikes should be three times the width of 5-HT spikes,
yet we observed a 6-fold difference. The model also predicts that the
widest diffusion-limited spikes, which would occur for a release site
that is the maximum possible distance from the electrode, should be 22 ms for 5-HT and 58 ms for insulin. Experimentally, we found that none
of the 5-HT spikes were broader than this maximum value. In contrast, 45% of the insulin spikes were over the maximum diffusion-limited width. Taken together, these results indicate that release of 5-HT is
indistinguishable from diffusion control and that a factor other than
diffusion contributes to slowing down the kinetics of release of
insulin.
Fig. 2.
Comparison of isolated spike shapes for
insulin and 5-HT detection. Spikes are due to detection of insulin
(A), 5-HT with no prespike feature (B), and 5-HT
with a prespike feature (foot) (C).
[View Larger Version of this Image (9K GIF file)]
Another difference in shape was that 14% of the 5-HT spikes had a
small current increase or "foot" prior to the rapid increase to the
spike apex, as shown in Fig. 2C. In contrast, such features were not observed on spikes due to detection of insulin at
physiological pH. Prespike features like those seen for 5-HT detection
have also been observed in the detection of catecholamine release from adrenal chromaffin cells (16, 25) and 5-HT release from mast cells
(21). This shape has been attributed to leakage of material from a
fusion pore that forms prior to complete opening of the vesicle (16,
21, 25). The lack of a foot for detection of insulin suggests that
insulin does not leak from a fusion pore in quantities that are
detectable.
Effects of Extracellular pH on Insulin Extrusion
To evaluate
the effect of extracellular pH on exocytosis, single cell recordings of
insulin secretion were made following tolbutamide stimulation when the
extracellular pH was 6.40, 6.90, 7.05, 7.20, 7.40, and 7.90. Similar
experiments were performed for detection of 5-HT secretion from loaded
cells at pH 6.40, 7.10, and 7.40. Fig. 3
summarizes the spike widths and areas that were recorded in these
different experiments. As mentioned under "Introduction," the area
of isolated current spikes is considered a direct measure of the amount
of product (insulin or 5-HT in this case) detected from a single
vesicle (19). Spike area for insulin detection is not significantly
changed by increasing extracellular pH above 6.9 (Fig. 3A);
however, no spikes were detected at pH 6.4. In contrast, the width at
half-height of spikes decreased with increasing pH for insulin
detection. The constant area combined with decreasing width caused an
increase in amplitude with increasing pH for insulin detection. In
contrast, the area and width at half-height for 5-HT current spike
detection was unaffected at any pH tested.
Fig. 3.
Comparison of insulin and 5-HT secretory area
and width at half-height at different extracellular pH values.
A, mean spike area obtained versus extracellular
pH for insulin and 5-HT; B, mean half-width of spikes
obtained versus extracellular pH for insulin and 5-HT. The
asterisk (*) indicates that the difference from pH 7.4 had a
significance of p < 0.0005. For insulin detection, numbers of spikes (n) were 53, 84, 15, 50, and 80 for pH
6.90, 7.05, 7.20, 7.40, and 7.90, respectively. For 5-HT detection, numbers of spikes (n) were 130, 84, and 107 for pH 6.40, 7.10, and 7.40, respectively. In all cases, at least four different cells were used to collect the spikes used.
[View Larger Version of this Image (23K GIF file)]
Effects of Intravesicular pH on Insulin and 5-HT Extrusion
To
investigate the effect of the vesicular proton pump and lowered
vesicular pH on insulin and 5-HT secretion, the effect of Bafilomycin
A1 and N-ethylmaleimide, compounds known to
inhibit V-type H+-ATPase activity and raise vesicular pH to
cytoplasmic pH (44, 45), on spike shapes was evaluated. Fig.
4 compares typical current traces
recorded at untreated cells and cells incubated with 1 µM
Bafilomycin A1 or 50 µM
N-ethylmaleimide. As observed from an inspection of these
plots, the number of spikes per stimulation, duration of secretory
activity, and area of the spikes are not significantly different for
any of these treatments.
Fig. 4.
Current recordings obtained from detection of
insulin following treatment with control (A), 1 µM Bafilomycin A1 (B), and 50 µM N-ethylmaleimide (C).
Treatments performed as described under "Materials and Methods."
Bars under current traces represent application of
stimulant. Dips in the current traces are a result of nonfaradaic
processes due to stimulation. Recordings are from different
cells.
[View Larger Version of this Image (15K GIF file)]
Although overall secretory activity for insulin was unaffected by
ATPase inhibition, insulin spike shape was affected as illustrated in
Fig. 5, A-C, and summarized
in Fig. 5D. The spike width was significantly decreased
(p < 0.001) by treatment with both agents. Furthermore, after treatment with Bafilomycin A1, 10% of
the detected spikes exhibited a foot, and after treatment with
N-ethylmaleimide 18% of spikes had this feature. Spike
samples shown in Fig. 5, B and C, are typical of
those that had a foot. As stated above, no spikes obtained from
untreated cells had such prespike features. In contrast, the spike
width for 5-HT was unaffected (Fig. 5D), and there was no
effect on the percentage of 5-HT spikes with feet.
Fig. 5.
Comparison of isolated current spikes
obtained from detection of insulin following treatment with control
(A), 1 µM Bafilomycin A1
(B), and 50 µM N-ethylmaleimide
(C). Spikes in B and C are
examples that display a foot. D, comparison of spike
half-widths for insulin and 5-HT spikes following treatment with V-type
H+-ATPase blockers. The asterisk (*) indicates
that half-width was different from control with a significance of
p < 0.001. For insulin detection, numbers of spikes
(n) were 49, 230, and 145 for no treatment, 50 µM N-ethylmaleimide, and 1 µM
Bafilomycin A1, respectively. For 5-HT detection,
n values were 132, 65, and 140 for no treatment, 50 µM N-ethylmaleimide, and 1 µM
Bafilomycin A1, respectively. Spikes were obtained from at
least six different cells for each experiment. Other conditions the
same as in Fig. 4.
[View Larger Version of this Image (15K GIF file)]
Effects of Extracellular Zn2+ Concentration on Insulin
and 5-HT Extrusion
In addition to the effects of pH, the effects
of 0, 5, 15, and 25 µM extracellular Zn2+ on
secretion measurements were examined. Fig.
6 illustrates typical secretion
measurements of insulin and 5-HT under these different conditions. As
extracellular Zn2+ concentration increased, the area of
insulin spikes decreased while the half-width increased, as summarized
in Fig. 7. These combined effects caused
spike amplitudes to decrease and result in detection of smaller numbers
of spikes as illustrated in Fig. 6. The smaller number of spikes is
presumed to result from fewer spikes being above the noise level
because of the decreased amplitudes. This effect is maximized at 25 µM Zn2+, at which no insulin spikes were
detected (data not shown). In contrast, when measuring 5-HT release,
the area and half-width of the spikes were not significantly different
at any given Zn2+ concentration (see Figs. 6 and 7).
Fig. 6.
Current recordings obtained from detection of
insulin with 0 µM extracellular Zn2+
(A), insulin with 15 µM extracellular
Zn2+ (B), 5-HT with 0 µM
extracellular Zn2+ (C), and 5-HT with 15 µM extracellular Zn2+ (D).
Bars under current traces represent application of
stimulant. Recordings are from different cells. Scale represents 10 pA
(A), 5 pA (B), and 20 pA (C and
D). Traces A and B were digitally low pass filtered at 30 Hz for presentation purposes.
[View Larger Version of this Image (11K GIF file)]
Fig. 7.
Comparison of insulin and 5-HT secretory area
and width at half-height at different extracellular
[Zn2+]. A, effect of extracellular
[Zn2+] on mean spike area for insulin and 5-HT. The
asterisk (*) indicates difference from 0 µM
[Zn2+] at a significance of p < 0.10, and ** indicates difference at p < 0.02. B,
effect of extracellular [Zn2+] on mean half-width of
spikes for insulin and 5-HT. The asterisk (*) indicates
difference from 0 µM [Zn2+] at a
significance of p < 0.001, and ** indicates difference at p < 0.01. For detection of insulin, numbers of
spikes (n) were 76, 68, and 22, whereas for detection of
5-HT, n values were 198, 75, and 70 for 0, 5, and 15 µM extracellular zinc, respectively. For all experiments,
at least five different cells were used.
[View Larger Version of this Image (19K GIF file)]
DISCUSSION
Dynamics of Exocytosis Events
Although 5-HT is released
simultaneously with insulin, it escapes from the vesicle at a
significantly higher rate, as evidenced by the narrower spikes and the
presence of feet, which suggest leakage out of vesicles during fusion
pore formation. 5-HT release is indistinguishable from simple diffusion
out of the vesicle, whereas insulin release is slower, suggesting that
a factor other than diffusion controls postfusion release. These
results may be explained by considering differences in storage of the
two secretory products. Although the exact form that 5-HT is stored in
the vesicles is unknown, it is reasonable to expect that it is stored
in solution because 5-HT is highly soluble at the vesicular pH. In
contrast, insulin is stored as a solid complex of
Zn2+-insulin (4, 5, 12). In addition, the electrode only
detects free insulin and not Zn2+-bound insulin, as
illustrated in Fig. 1. Therefore, it seems likely from these
considerations that the dissolution and dissociation of
Zn2+-insulin complex controls the rate of insulin extrusion
during exocytosis.
Effects of Extracellular and Intravesicular pH
In our initial
work, we demonstrated that a change in extracellular pH from 7.4 to 6.4 could hinder insulin clearance to such an extent as to make it
undetectable by amperometry while having no effect on 5-HT secretion
(37). The data in Fig. 3, obtained over a wider pH range, show that
decreasing extracellular pH from 7.9 to 6.9 increases the time required
for insulin clearance (increasing spike width) but does not affect the
amount of insulin released during an exocytosis event (no change in
area). 5-HT secretion is unaffected in this pH range (Fig. 3), proving
that this effect is specific to insulin extrusion and is not an effect
on vesicular fusion. Further investigation has revealed that increasing
vesicular pH with V-type H+-ATPase inhibitors, which is
expected to change the storage conditions for insulin, causes insulin
to be more rapidly extruded (as demonstrated by narrower spikes) and
even leak out of fusion pores (as demonstrated by the presence of
feet). This effect suggests that some dissolution of the insulin
granule occurs inside the vesicle when the vesicular pH is raised.
Therefore, under normal conditions, low pH inside the vesicle maintains
insulin in a solid state that does not escape as readily during fusion
pore formation or vesicle fusion. These results further emphasize the
importance of the pH gradient between the vesicle and extracellular
media in rapidly changing insulin from a solid, storage state to a
dissolved, releasable form. These results also highlight the difference
between postfusion release of other hormones and insulin. For example,
in catecholamine release from adrenal chromaffin cells, increasing the
pH has the effect of increasing the time course of postfusion extrusion
(25). Furthermore, the effects of pH on catecholamine release are not nearly as dramatic as those observed here. These differences can be
attributed to differences in storage of the compounds. In the case of
catecholamine, release requires the unraveling of a protein gel rather
than dissolution of a solid-state hormone (25).
Effect of Zn2+ on Insulin Extrusion
In addition
to dissolving, the insulin-Zn2+ complex must ultimately
dissociate after vesicle fusion because the active form of insulin is a
monomer (14, 15). We have postulated that availability of extracellular
Zn2+ may affect the release of free insulin from beta cells
through a common-ion effect. Extracellular Zn2+
concentrations in the range of 5-25 µM markedly
decreased area and increased width of insulin spikes without affecting
5-HT spikes. The lack of an effect on 5-HT detection demonstrates that
the effect is specific to insulin extrusion and not to earlier steps in
exocytosis. Unlike pH manipulations, extracellular Zn2+ not
only increased the time course of release of free insulin, but also
decreased the amount of free insulin detected from an exocytosis event.
Decreases in amount of free insulin detected occurred even though
half-widths of detected spikes suggest that a release event is
occurring at a fast enough rate to yield a detectable spike. A possible
explanation for this result is that after vesicle fusion, the
Zn2+-insulin hexamer dissolves but does not dissociate
because of the high extracellular Zn2+ concentration,
allowing most of the insulin to escape from the detection area in the
undetectable Zn2+-insulin complex form. Interestingly, the
effects of Zn2+ on insulin secretion are similar to those
observed for catecholamine secretion from adrenal chromaffin cells
(46). Although Zn2+ decreased the quanta in both cases, the
chemical mechanisms are different. Rather than a common ion effect on
complex, the Zn2+ effect on catecholamine secretion was due
to the ability of Zn2+ to cross-link the protein matrix in
chromaffin cell vesicles and hinder the escape of the hormone (46).
The results presented here demonstrate that micromolar Zn2+
concentrations can affect free insulin concentration in the immediate vicinity of a beta cell during secretion. The possible physiological significance of the Zn2+ effect is not clear because the
actual concentration of Zn2+ in the interstitial space of
an islet is not known; however, Zn2+ concentration in serum
is approximately 15-25 µM (47-50). It has previously
been demonstrated that in vivo insulin is available as free
monomer within a few seconds of entering the portal vein, presumably
because the large dilution of insulin drives dissociation (4);
therefore, it seems unlikely that extracellular Zn2+ could
affect the endocrine function of free insulin.
Regulation of Insulin Extrusion during Exocytosis
Our
observations show that free insulin concentrations in the vicinity of
beta cells are affected by the intravesicular pH and extracellular pH
and Zn2+ concentrations. These results have been
interpreted as effects on the rate of dissolution and dissociation as
Zn2+-insulin hexamers during exocytosis. This
interpretation ignores the possible role of vesicle matrix proteins,
such as chromagranin, in storing and extruding free insulin. In adrenal
chromaffin cells and mast cells, glycoproteins, such as chromagranin,
in the vesicle matrix have been shown to be critical in storing and
then extruding the secretory products (51-54). These studies have
shown that matrix proteins help release the secretory products in a
pH-dependent mechanism that involves ion exchange and phase
transition of the storage proteins (51-54). Chromagranin is found in
the secretory vesicles of beta cells (55-57) and therefore could play
a similar role in extruding insulin. Our data cannot exclude such a
possibility; however, it seems unlikely, given the differences in
storage of insulin in beta cells and histamine or catecholamines in the
other cells types. First, insulin is stored as a solid (4, 5, 6) and
therefore is not associated with the chromagranin. Second, histochemical evidence shows that chromagranin in beta cell secretory vesicles is concentrated in the halo region separate from insulin in
the dense core (57). Finally, in beta cell vesicles, insulin and
C-peptide make up 80% of the protein content, and membrane-bound proteins make up 10%, leaving just 10% of the total protein as matrix
proteins (58). Such a distribution would seem to preclude a dominant
role for chromagranin in storing and dispersing insulin, especially
given the importance of Zn2+-insulin complex formation in
storage.
This study has revealed some of the chemical events involved in driving
postfusion release of insulin from beta cells. The effects of
H+ and Zn2+ on insulin release that were
observed are a natural manifestation of the complex mechanism of
insulin synthesis and storage. The fact that the quanta of insulin
release and the rate of insulin release can be altered also raises the
possibility that insulin secretion can be regulated by the
intravesicular and extracellular ionic environment. Such postfusion
control of release has recently been proposed as a novel regulatory
mechanism in a variety of cell types (52). Postfusion regulation of
insulin release would seem to hold little relevance to the endocrine
action of insulin given the large distance between the release site and
the site of action. However, several lines of evidence support the
notion of an autocrine and/or paracrine role for insulin within an
islet. Specifically, insulin has been demonstrated to (a)
bind to islet cells (59), (b) affect insulin secretion (61,
62), and (c) activate insulin receptors in beta cell lines
(60, 33). Therefore, if the intravesicular or extracellular ionic
environment does mediate postfusion regulation of insulin release, then
its effects would likely be exerted at the level of autocrine or
paracrine signaling of insulin.
FOOTNOTES
*
This research was supported in part by National Institutes
of Health Grant RO1 DK46960-01 from the NIDDK and by the Juvenile Diabetes Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Received support as a Presidential Faculty Fellow and an Alfred P. Sloan Fellow. To whom correspondence should be addressed, at the
Department of Chemistry, University of Florida, P. O. Box 117200, Gainesville, FL 32611-7200. Tel.: 352-392-9839; Fax: 352-392-4582; E-mail: rtkenn{at}chem.ufl.edu.
Supported by a postdoctoral fellowship from the Alberta
Heritage Foundation for Medical Research.
1
The abbreviation used is: 5-HT,
5-hydroxytryptamine.
2
C. A. Aspinwall, S. A. Brooks, J. R. T. Lakey, and R. T. Kennedy, submitted for
publication.
REFERENCES
-
Unger, R. H.
(1991)
Science
251,
1200-1205
[Abstract/Free Full Text]
-
Rajan, A. S., Aguilar-Bryan, L., Nelson, D. A., Yaney, G. C., Hsu, W. H., Kunze, D. L., and Boyd, A. E., III
(1990)
Diabetes Care
13,
340-363
[Abstract]
-
Zimmerberg, J.
(1987)
Biosci. Rep.
7,
251-268
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gold, G., and Grodsky, G. M.
(1984)
Experentia
40,
1105-1114
[CrossRef][Medline]
[Order article via Infotrieve]
-
Blundell, T., Dodson, G., Hodkin, D., and Mercola, D.
(1972)
Adv. Protein Chem.
26,
279-402
[CrossRef]
-
Emdin, S. O., Dodson, G. G., Cutfield, J. M., and Cutfield, S. M.
(1980)
Diabetologia
19,
174-189
[CrossRef][Medline]
[Order article via Infotrieve]
-
Foster, M. C., Leapman, R. D., Li, M. X., and Atwater, I.
(1993)
Biophys. J.
64,
525-532
[Medline]
[Order article via Infotrieve]
-
Tanford, C., and Epstein, J.
(1954)
J. Am. Chem. Soc.
76,
2170-2176
[CrossRef]
-
Epand, R. M., Stafford, A. R., Tyers, M., and Nieboer, E.
(1985)
Mol. Pharmacol.
27,
366-374
[Abstract]
-
Orci, L., Ravazzola, M., Amherdt, M., Madsen, O., Perrelet, A., Vassalli, J.-D., and Anderson, R. G. W.
(1986)
J. Cell Biol.
103,
2273-2281
[Abstract/Free Full Text]
-
Hutton, J. C.
(1982)
Biochem. J.
204,
171-178
[Medline]
[Order article via Infotrieve]
-
Orci, L.
(1985)
Diabetologia
28,
528-546
[Medline]
[Order article via Infotrieve]
-
Coore, H. G., Hellman, B., Pihl, E., and Täljedal, I.-B.
(1969)
Biochem. J.
111,
107-113
[Medline]
[Order article via Infotrieve]
-
Berson, S. A., and Yalow, R. S.
(1966)
Am. J. Med.
40,
676-690
[CrossRef][Medline]
[Order article via Infotrieve]
-
Helmerhorst, E., and Stokes, G. B.
(1986)
Arch. Biochem. Biophys.
245,
238-247
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chow, R. H., von Ruden, L., and Neher, E.
(1992)
Nature
356,
60-62
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ciolkowski, E. L., Cooper, B. R., Jankowski, J. A., Jorgenson, J. W., and Wightman, R. M
(1992)
J. Am. Chem. Soc.
114,
2815-2821
[CrossRef]
-
Leszczyszyn, D. J., Jankowski, J. A., Viveros, O. H., Diliberto, E. J., Jr., Near, J. A., and Wightman, R. M.
(1990)
J. Biol. Chem.
265,
14736-14737
[Abstract/Free Full Text]
-
Wightman, R. M., Jankowski, J. A., Kennedy, R. T., Kawagoe, K. T., Schroeder, T. J., Leszczyszyn, D. J., Near, J. A., Diliberto, E. J., and Viveros, O. H.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
10754-10758
[Abstract/Free Full Text]
-
Chen, T. K., Luo, G., and Ewing, A. G.
(1994)
Anal. Chem.
66,
3031-3035
[Medline]
[Order article via Infotrieve]
-
Alvarez de Toledo, G., Fernandez-Chacon, R., and Fernandez, J. M.
(1993)
Nature
363,
554-558
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhou, Z., and Misler, S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6938-6942
[Abstract/Free Full Text]
-
Paras, C. D., and Kennedy, R. T.
(1995)
Anal. Chem.
67,
3633-3637
[Medline]
[Order article via Infotrieve]
-
Paras, C. D., and Kennedy, R. T.
(1997)
Electroanalysis
9,
203-208
[CrossRef]
-
Jankowski, J. A., Schroeder, T. J., Ciolkowski, E. L., and Wightman, R. M.
(1993)
J. Biol. Chem.
268,
14694-14700
[Abstract/Free Full Text]
-
Jankowski, J. A., Finnegan, J. M., and Wightman, R. M.
(1994)
J. Neurochem.
63,
1739-1747
[Medline]
[Order article via Infotrieve]
-
Borges, R., Travis, E. R., Hochstetler, S. E., and Wightman, R. M.
(1997)
J. Biol. Chem.
272,
8325-8331
[Abstract/Free Full Text]
-
Walker, A., Glavinovic, M. I., and Trifaro, J.-M.
(1996)
Pfluegers Arch. Eur. J. Physiol.
431,
729-735
[Medline]
[Order article via Infotrieve]
-
Fernandez-Chacon, R., and de Toledo, G. A.
(1995)
FEBS Lett.
363,
221-225
[CrossRef][Medline]
[Order article via Infotrieve]
-
Oberhauser, A. F., Robinson, I. M., and Fernandez, J. M.
(1996)
Biophys. J.
71,
1131-1139
[Medline]
[Order article via Infotrieve]
-
Huang, L., Shen, H., Atkinson, M. A., and Kennedy, R. T.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
608-612
-
Kennedy, R. T., Huang, L., Atkinson, M. A., and Dush, P.
(1993)
Anal. Chem.
65,
1882-1887
[Medline]
[Order article via Infotrieve]
-
Gazzano, H., Halban, P., Prentki, M., Ballotti, R., Brandenburg, D., Fehlmann, M., and Van Obberghen, E.
(1985)
Biochem. J.
226,
867-872
[Medline]
[Order article via Infotrieve]
-
Smith, P. A., Duchen, M. R., and Ashcroft, F. M.
(1994)
J. Physiol.
475P,
157P
-
Smith, P. A., Duchen, M. R., and Ashcroft, F. M.
(1995)
Pfluegers Arch. Eur. J. Physiol.
430,
808-818
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhou, Z., and Misler, S.
(1996)
J. Biol. Chem.
271,
270-277
[Abstract/Free Full Text]
-
Kennedy, R. T., Huang, L., and Aspinwall, C. A.
(1996)
J. Am. Chem. Soc.
118,
1795-1796
[CrossRef]
-
Kawagoe, K. T., Zimmerman, J. B., and Wightman, R. M.
(1993)
J. Neurosci. Methods
48,
225-240
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kelly, R. S., and Wightman, R. M.
(1986)
Anal. Chim. Acta
187,
79-87
-
Ricordi, C., Lacy, P. E., Finke, E. H., Olack, B. J., and Scharp, D. W.
(1988)
Diabetes
37,
413-420
[Abstract]
-
Warnock, G. L., Ao, Z., Lakey, J. R. T., and Rajotte, R. V.
(1994)
in
Pancreatic Islet Transplantation Vol I: Procurement of Pancreatic Islets (Lanza, R. P., and Chick, W. L., eds), pp. 81-95, R. G. Landes, Austin, TX
-
Barnett, D. W., Pressel, D. M., Chern, H. T., Scharp, D. W., and Misler, S.
(1994)
J. Membr. Biol.
138,
113-120
[Medline]
[Order article via Infotrieve]
-
Schroeder, T. J., Jankowski, J. A., Kawagoe, K. T., Wightman, R. M., Lefrou, C., and Amatore, C.
(1992)
Anal. Chem.
64,
3077-3083
[Medline]
[Order article via Infotrieve]
-
Bowman, E. J., Siebers, A., and Altendorf, K.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
7972-7976
[Abstract/Free Full Text]
-
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., and Tashiro, Y.
(1991)
J. Biol. Chem.
266,
17707-17712
[Abstract/Free Full Text]
-
Pihel, K., Travis, E. R., Borges, R., and Wightman, R. M.
(1996)
Biophys. J.
71,
1633-1640
[Medline]
[Order article via Infotrieve]
-
Hurley, L. S.
(1969)
Am. J. Clin. Nutr.
22,
1332-1341
[Abstract]
-
Chen, M.-D., Lin, P.-Y., Tsuo, C.-T., Wang, J.-J., and Lin, W.-H.
(1995)
Biol. Trace Element Res.
50,
119-124
[Medline]
[Order article via Infotrieve]
-
Zalewski, P. D., Forbes, I. J., and Betts, W. H.
(1993)
Biochem. J.
296,
403-408
-
Bonner, F. W., King, L. J., and Parke, D. V.
(1979)
Chem. Biol. Interact.
27,
343-351
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nanavati, C., and Fernandez, J. M.
(1993)
Science
259,
963-965
[Abstract]
-
Rahamimoff, R., and Fernandez, J. M.
(1997)
Neuron
18,
17-27
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wightman, R. M., Schroeder, T. J., Finnegan, J. M., Ciolkowski, E. L., and Pihel, K.
(1995)
Biophys. J.
68,
383-390
[Medline]
[Order article via Infotrieve]
-
Schroeder, T. J., Borges, R., Finnegan, J. M., Pihel, K., Amatore, C., and Wightman, R. M.
(1996)
Biophys. J.
70,
1061-1068
[Medline]
[Order article via Infotrieve]
-
Ehrhart, M., Grube, D., Bader, M. F., Aunis, D., and Gratzl, M.
(1986)
J. Histochem. Cytochem.
34,
1673-1682
[Abstract]
-
Hutton, J. C., Peshavakia, M., Johnston, C. F., Ravazzola, M., and Orci, L.
(1988)
Endocrinology
122,
1014-1020
[Abstract/Free Full Text]
-
Guest, P. C., Rhodes, C. J., and Hutton, J. C.
(1989)
Biochem. J.
257,
431-437
[Medline]
[Order article via Infotrieve]
-
Hutton, J. C.
(1989)
Diabetologia
32,
271-281
[CrossRef][Medline]
[Order article via Infotrieve]
-
Patel, Y. C., Amherdt, M., and Orci, L.
(1982)
Science
217,
1155-1156
[Abstract/Free Full Text]
-
Rothenberg, P. L., Willison, L. D., Simon, J., and Wolf, B. A.
(1995)
Diabetes
44,
802-809
[Abstract]
-
Xu, G., Howland, J., and Rothenberg, P. L.
(1996)
Biochem. J.
318,
623-629
-
Hazelwood, R. L.
(1989)
The Endocrine Pancreas, Prentice Hall, Englewood Cliffs, NJ
Volume 272, Number 50,
Issue of December 12, 1997
pp. 31308-31314
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Tremblay, A.-M. T. Richard, S. Will, J. Syed, N. Stedman, M. Perreault, and R. E. Gimeno
Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo
Endocrinology,
June 1, 2009;
150(6):
2586 - 2595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. de Wit, R. F. Toonen, and M. Verhage
Matrix-Dependent Local Retention of Secretory Vesicle Cargo in Cortical Neurons
J. Neurosci.,
January 7, 2009;
29(1):
23 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. MacDonald and P. Rorsman
The Ins and Outs of Secretion from Pancreatic {beta}-Cells: Control of Single-Vesicle Exo- and Endocytosis
Physiology,
April 1, 2007;
22(2):
113 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Stiernet, Y. Guiot, P. Gilon, and J.-C. Henquin
Glucose Acutely Decreases pH of Secretory Granules in Mouse Pancreatic Islets: MECHANISMS AND INFLUENCE ON INSULIN SECRETION
J. Biol. Chem.,
August 4, 2006;
281(31):
22142 - 22151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Brigadski, M. Hartmann, and V. Lessmann
Differential Vesicular Targeting and Time Course of Synaptic Secretion of the Mammalian Neurotrophins
J. Neurosci.,
August 17, 2005;
25(33):
7601 - 7614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. Prost, A. Bloc, N. Hussy, R. Derand, and M. Vivaudou
Zinc is both an intracellular and extracellular regulator of KATP channel function
J. Physiol.,
August 15, 2004;
559(1):
157 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Eto, T. Yamashita, K. Hirose, Y. Tsubamoto, E. K. Ainscow, G. A. Rutter, S. Kimura, M. Noda, M. Iino, and T. Kadowaki
Glucose metabolism and glutamate analog acutely alkalinize pH of insulin secretory vesicles of pancreatic {beta}-cells
Am J Physiol Endocrinol Metab,
August 1, 2003;
285(2):
E262 - E271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Tompkins, K. D. Nullmeyer, S. M. Murphy, C. S. Weber, and R. M. Lynch
Regulation of secretory granule pH in insulin-secreting cells
Am J Physiol Cell Physiol,
August 1, 2002;
283(2):
C429 - C437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N Pothos, E. Mosharov, K.-P. Liu, W. Setlik, M. Haburcak, G. Baldini, M. D Gershon, H. Tamir, and D. Sulzer
Stimulation-dependent regulation of the pH, volume and quantal size of bovine and rodent secretory vesicles
J. Physiol.,
July 15, 2002;
542(2):
453 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, J. Wu, N. Cui, L. Abdulkadir, R. Wang, J. Mao, L. R. Giwa, S. Chanchevalap, and C. Jiang
Distinct Histidine Residues Control the Acid-induced Activation and Inhibition of the Cloned KATP Channel
J. Biol. Chem.,
October 12, 2001;
276(42):
38690 - 38696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bloc, T. Cens, H. Cruz, and Y. Dunant
Zinc-induced changes in ionic currents of clonal rat pancreatic {beta}-cells: activation of ATP-sensitive K+ channels
J. Physiol.,
December 15, 2000;
529(3):
723 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Williams and W. Webb
Single granule pH cycling in antigen-induced mast cell secretion
J. Cell Sci.,
January 11, 2000;
113(21):
3839 - 3850.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-N. Yang, O. Larsson, R. Branstrom, A. M. Bertorello, B. Leibiger, I. B. Leibiger, T. Moede, M. Kohler, B. Meister, and P.-O. Berggren
Syntaxin 1 interacts with the LD subtype of voltage-gated Ca2+ channels in pancreatic beta cells
PNAS,
August 31, 1999;
96(18):
10164 - 10169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Aspinwall, J. R. T. Lakey, and R. T. Kennedy
Insulin-stimulated Insulin Secretion in Single Pancreatic Beta Cells
J. Biol. Chem.,
March 5, 1999;
274(10):
6360 - 6365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Han, D. Li, A. K. Stout, K. Takimoto, and E. S. Levitan
Ca2+-Induced Deprotonation of Peptide Hormones Inside Secretory Vesicles in Preparation for Release
J. Neurosci.,
February 1, 1999;
19(3):
900 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, N. Cui, Z. Yang, J. Wu, L. R. Giwa, L. Abdulkadir, P. Sharma, and C. Jiang
Direct Activation of Cloned KATP Channels by Intracellular Acidosis
J. Biol. Chem.,
April 13, 2001;
276(16):
12898 - 12902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Zawalich, G. J. Tesz, and K. C. Zawalich
Are 5-Hydroxytryptamine-preloaded beta -Cells an Appropriate Physiologic Model System for Establishing That Insulin Stimulates Insulin Secretion?
J. Biol. Chem.,
September 28, 2001;
276(40):
37120 - 37123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Aspinwall, W.-J. Qian, M. G. Roper, R. N. Kulkarni, C. R. Kahn, and R. T. Kennedy
Roles of Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, and Release of Intracellular Ca2+ Stores in Insulin-stimulated Insulin Secretion in beta -Cells
J. Biol. Chem.,
July 14, 2000;
275(29):
22331 - 22338.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|